Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
Background: Induction therapy regimens classified as conventional immunosuppressive agents and lower doses of conventional agents combined with antibodies against T-cell antigens have been purposed to prevent acute rejection after renal transplantation. Various induction agents with different doses...
Main Authors: | A Khalafi-Nezhad, MM Sagheb, F Amirmoezi, Z Jowkar, AR Dehghanian |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2015-10-01
|
Series: | International Journal of Organ Transplantation Medicine |
Subjects: | |
Online Access: | http://www.ijotm.com/ojs/index.php/IJOTM/article/view/230 |
Similar Items
-
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
by: Masashi Furukawa, et al.
Published: (2022-06-01) -
Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
by: Martina Guthoff, et al.
Published: (2020-05-01) -
Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
by: Marieke van der Zwan, et al.
Published: (2020-07-01) -
Early primary graft failure after a pediatric heart transplant and successful rescue with plasmapheresis, immunoglobulins, and alemtuzumab
by: Shashi Raj, et al.
Published: (2017-01-01) -
Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
by: Anil J. Trindade, et al.
Published: (2020-05-01)